Summary

Gold Nanoparticles Market – Scope of Report
TMR’s report on the global gold nanoparticles market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global gold nanoparticles market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gold nanoparticles market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the gold nanoparticles market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gold nanoparticles market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global gold nanoparticles market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gold nanoparticles market.

The report delves into the competitive landscape of the global gold nanoparticles market. Key players operating in the global gold nanoparticles market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global gold nanoparticles market profiled in this report.

Key Questions Answered in Global gold nanoparticles Market Report
• What is the sales/revenue generated by gold nanoparticles across all regions during the forecast period?
• What are the opportunities in the global gold nanoparticles market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Gold Nanoparticles Market – Research Objectives and Research Approach
The comprehensive report on the global gold nanoparticles market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global gold nanoparticles market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global gold nanoparticles market.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Gold Nanoparticles Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Gold Nanoparticles Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Gold Nanoparticles Market Analysis and Forecast, by Application
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2023–2031
6.3.1. Imaging
6.3.2. Targeted Drug Delivery
6.3.3. Proton Therapy
6.3.4. In-Vitro Assays
6.3.5. Sensors
6.3.6. Probes
6.3.7. Catalysis
6.3.8. Other Applications
6.3.9. 6.4 Market Attractiveness, by Application
7. Gold Nanoparticles Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023–2031
7.3.1. Healthcare
7.3.2. Electronics
7.3.3. Chemicals
7.3.4. Others
7.4. Market Attractiveness, by End-user
8. Gold Nanoparticles Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Gold Nanoparticles Market Analysis and Forecast
9.1. Market Value Forecast, by Application, 2023–2031
9.1.1. Imaging
9.1.2. Targeted Drug Delivery
9.1.3. Proton Therapy
9.1.4. In-Vitro Assays
9.1.5. Sensors
9.1.6. Probes
9.1.7. Catalysis
9.1.8. Other Applications
9.2. Market Attractiveness, by Application
9.3. Market Value Forecast, by End-user, 2023–2031
9.3.1. Healthcare
9.3.2. Electronics
9.3.3. Chemicals
9.3.4. Others
9.4. Market Attractiveness, by End-user
9.5. Market Value Forecast, by Country, 2023–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Application
9.6.2. By End-user
9.6.3. By Country
10. Europe Gold Nanoparticles Market Analysis and Forecast
10.1. Market Value Forecast, by Application, 2023–2031
10.1.1. Imaging
10.1.2. Targeted Drug Delivery
10.1.3. Proton Therapy
10.1.4. In-Vitro Assays
10.1.5. Sensors
10.1.6. Probes
10.1.7. Catalysis
10.1.8. Other Applications
10.2. Market Attractiveness, by Application
10.3. Market Value Forecast, by End-user, 2023–2031
10.3.1. Healthcare
10.3.2. Electronics
10.3.3. Chemicals
10.3.4. Others
10.4. Market Attractiveness, by End-user
10.5. Market Value Forecast, by Country/Sub-region, 2023–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Gold Nanoparticles Market Analysis and Forecast
11.1. Market Value Forecast, by Application, 2023–2031
11.1.1. Imaging
11.1.2. Targeted Drug Delivery
11.1.3. Proton Therapy
11.1.4. In-Vitro Assays
11.1.5. Sensors
11.1.6. Probes
11.1.7. Catalysis
11.1.8. Other Applications
11.2. Market Attractiveness, by Application
11.3. Market Value Forecast, by End-user, 2023–2031
11.3.1. Healthcare
11.3.2. Electronics
11.3.3. Chemicals
11.3.4. Others
11.4. Market Attractiveness, by End-user
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Gold Nanoparticles Market Analysis and Forecast
12.1. Market Value Forecast, by Application, 2023–2031
12.1.1. Imaging
12.1.2. Targeted Drug Delivery
12.1.3. Proton Therapy
12.1.4. In-Vitro Assays
12.1.5. Sensors
12.1.6. Probes
12.1.7. Catalysis
12.1.8. Other Applications
12.2. Market Attractiveness, by Application
12.3. Market Value Forecast, by End-user, 2023–2031
12.3.1. Healthcare
12.3.2. Electronics
12.3.3. Chemicals
12.3.4. Others
12.4. Market Attractiveness, by End-user
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Gold Nanoparticles Market Analysis and Forecast
13.1. Market Value Forecast, by Application, 2023–2031
13.1.1. Imaging
13.1.2. Targeted Drug Delivery
13.1.3. Proton Therapy
13.1.4. In-Vitro Assays
13.1.5. Sensors
13.1.6. Probes
13.1.7. Catalysis
13.1.8. Other Applications
13.2. Market Attractiveness, by Application
13.3. Market Value Forecast, by End-user, 2023–2031
13.3.1. Healthcare
13.3.2. Electronics
13.3.3. Chemicals
13.3.4. Others
13.4. Market Attractiveness, by End-user
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. BBI Solutions
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. TANAKA
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Johnson Matthey Plc
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Nanopartz Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Nanocomposix Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Meliorum Technologies, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Sigma Aldrich
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Innova Biosicences
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Cline Scientific
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Cytodiagnostics
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview